We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Diagnostics – Products

Two blood samples.
Product News

PlaqueTec and the Babraham Institute Collaborate on Phenotypic Screen of Coronary Artery Blood

The project aims to investigate cell types present in coronary artery samples from patients with CAD participating in PlaqueTec’s BIOPATTERN trial. The Assay will be available as a service in the Babraham Institute’s Flow Cytometry Facility.
Microscopic image of engineered human skin.
Product News

AMSBIO Highlights Groundbreaking 2023 Life Science Research

In an informative new blog post - AMSBIO reflects on a selection of the groundbreaking life science and biomedical research undertaken by its customers during 2023.
Two vials of blood.
Product News

PlaqueTec Recruits First Ten Patients in BIOPATTERN Trial

PlaqueTec announced that it has received the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.
Cell-Free DNA
App Note / Case Study

Detecting Contaminants in Cell-Free DNA for Better Biomarker Discovery

This application note presents the latest electrophoretic solutions for a more rapid assessment of cfDNA samples and optimal biomarker discovery.
DNA bases.
Product News

Beckman Coulter Life Sciences and Pillar Biosciences Announce NGS Application Development Pipeline

Assays focus on accelerating cancer research.
The corner of a macbook.
Product News

Oxford Nanopore Meets Apple’s M3 Silicon Chip

CEO Gordon Sanghera discusses how Apple’s latest product announcement means complex processing required for DNA/RNA sequencing can now be run from the latest MacBook Pro™ or iMac ™.
Cancer Cell Target
App Note / Case Study

Discover the Future of Cancer Research With Whole-Genome Sequencing

To accelerate the discovery of new cancer biomarkers and new insights into the genetics of treatment-resistant tumors, it is crucial to gain a deeper understanding of the genomic and epigenomic variations in cancer.
A scientist holding a rack of blood samples.
Product News

Sebia Launches M-InSight®, a Test for Monitoring Multiple Myeloma Patients

Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma.
The automated DNA extraction machine.
Product News

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow.
Lab-on-a-chip plate technology for screening minute amounts of cancerous tissue.
Product News

Lab-on-Chip Technology for Screening Live Tumor

ScreenIn3D reports on how their proprietary lab-on-a-chip technology is enabling cancer researchers to miniaturize their testing of biopsy tissue samples across a wide range of modalities and to test both single and combination drug therapies.
Advertisement